Products

AiORTA – Plan v2.0
ViTAA Medical Solutions Inc.
Cardiology AI
AiORTA - Plan v2.0 is an AI-enabled radiological software tool by ViTAA Medical Solutions, Inc. designed for precise aortic planning and analysis.
AiORTA – Plan
ViTAA Medical Solutions
Radiology & Imaging AI
AiORTA - Plan is an FDA-cleared, AI-powered, web-based solution by ViTAA Medical Solutions that automates hyper-precise preoperative planning for aortic surgery, including aneurysm segmentation and volumetric analysis.

See all 2 products →

About ViTAA Medical Solutions

ViTAA Medical Solutions is a healthcare AI company dedicated to transforming the management of abdominal aortic aneurysms (AAA) through precision imaging and artificial intelligence. The company develops personalized medicine solutions aimed at providing physicians with enhanced insights into aortic health. Their flagship product, AiORTA™ Plan, has received U.S. FDA 510(k) clearance, marking a significant milestone in their platform strategy.

AiORTA™ Plan is a cloud-based, AI-powered software designed to automate critical preoperative measurements for aortic surgical cases. It streamlines the preparation process by generating a complete aortic plan in minutes, performing automated aneurysm segmentation, centerline extraction, precise diameter and angulation measurements, and instant volumetric modeling. This technology aims to improve the precision, reproducibility, and efficiency of aortic interventions, thereby reducing the manual workload for clinicians.

The broader AiORTA™ platform also includes AiORTA™ Maps and AiORTA™ Watch, which are currently undergoing multicenter clinical studies. AiORTA™ Maps is being developed to provide patient-specific vessel strength analysis by utilizing AI on CT scans to offer insights into thrombus burden and predict outcomes, ultimately generating a Regional Aortic Weakness (RAW) Score. AiORTA™ Watch focuses on longitudinal monitoring of aortic health for early detection of complications. By moving beyond traditional size-based assessments, ViTAA Medical Solutions seeks to enable more accurate risk stratification and facilitate timely, appropriate interventions for AAA patients, leading to improved clinical outcomes.

Focus Areas

Personalized medicine abdominal aortic aneurysms AI diagnostic imaging aortic surgery planning vessel strength analysis longitudinal monitoring cloud-based solutions computer vision machine learning

Business Intelligence

Key InvestorsUCeed, Boreal Ventures, INOVAIT, Third Culture Capital
PartnershipsUniversity of Calgary, Society of Vascular Surgery (potential endorsement)
TechnologyAiORTA™ platform (Plan, Maps, Watch), RAW Mapping technology, cloud-based software, AI-assisted 3D modeling, computer algorithms, in vivo strain analysis, optical-flow algorithm
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Specialization: Abdominal Aortic Aneurysms (AAA)
ViTAA Medical Solutions specializes in personalized medicine for patients diagnosed with abdominal aortic aneurysms (AAA). Their core focus is on improving the diagnosis, planning, and monitoring of this life-threatening condition by moving beyond traditional diameter-based assessments.
Key Differentiator: RAW Mapping Technology
ViTAA's proprietary 'Regions of Aortic Weakness (RAW) Mapping' technology processes existing CT scans to create a color-coded virtual map of aortic strength and weakness. This goes beyond simple diameter measurements by combining flow analysis, in vivo strain analysis, and intraluminal thrombus analysis to identify vulnerable areas.
Technology Stack: AI, Machine Learning & Computer Vision
The company leverages advanced AI-assisted 3D modeling, computer algorithms, machine learning, and computer vision to analyze diagnostic imaging data. Their AI models are trained to predict aneurysm growth and rupture with high accuracy.
Key Differentiator: Predictive Analytics & 'Glassbox' AI
ViTAA's AI system has demonstrated high accuracy in predicting which aneurysms will grow and rupture, with a reported 100% sensitivity and 92% specificity for rupture prediction. They emphasize a 'glassbox' AI approach, ensuring every step and decision is auditable and easily understood by physicians, fostering trust and transparency.
Product Suite: AiORTA Platform
ViTAA offers a comprehensive AiORTA platform, including AiORTA Plan for automated, hyper-precise aortic surgery planning (FDA 510(k) cleared), AiORTA Maps for patient-specific vessel strength analysis, and AiORTA Watch for longitudinal monitoring and early complication detection.
Technology Stack: Cloud-Based Solutions
Their solutions, such as AiORTA Plan, are delivered as zero-footprint, web-based systems, enabling automated pre-operative case planning and seamless integration into existing clinical workflows.
Physician Tip

For physicians, ViTAA Medical Solutions offers a transformative approach to AAA management. Their technology enables more precise identification of high-risk patients, allowing for earlier intervention when necessary, and provides confidence to delay treatment for lower-risk individuals, optimizing patient outcomes and reducing unnecessary surgeries. The detailed RAW maps and predictive analytics provide critical insights into vessel integrity, empowering surgeons to make more informed decisions for aortic surgery planning, including optimal stent placement in strong tissue to minimize post-surgical complications. The automated and cloud-based nature of AiORTA Plan streamlines preoperative workflows, saving time and improving planning consistency. Furthermore, the 'glassbox' AI design ensures transparency, building trust in the AI-driven recommendations. The full AiORTA platform aims to provide end-to-end, patient-specific vascular care across the entire disease continuum, from planning to long-term post-operative surveillance.

ViTAA's cloud-based solutions are designed for seamless integration into existing clinical workflows, utilizing readily available CT scan data. The web-based system configuration facilitates accessibility and reduces the need for local software installations.

Products by ViTAA Medical Solutions

2 products in the directory

AiORTA – Plan v2.0
ViTAA Medical Solutions Inc.
Cardiology AI
AiORTA - Plan v2.0 is an AI-enabled radiological software tool by ViTAA Medical Solutions, Inc. designed for precise aortic planning and analysis.
AiORTA – Plan
ViTAA Medical Solutions
Radiology & Imaging AI
AiORTA - Plan is an FDA-cleared, AI-powered, web-based solution by ViTAA Medical Solutions that automates hyper-precise preoperative planning for aortic surgery, including aneurysm segmentation and volumetric analysis.

Reviews & Opinions

No web reviews on file yet for ViTAA Medical Solutions. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about ViTAA Medical Solutions.

Loading videos...

Videos load interactively. If none appear, search YouTube for ViTAA Medical Solutions →

View all on YouTube

Press & Coverage

Vascular News
ViTAA Medical announces US FDA 510(k) clearance for aortic planning platform
ViTAA Medical received US FDA 510(k) clearance for AiORTA Plan, a fully automated, hyper-precise aortic surgery planning solution. This tool streamlines preoperative measurements and generates a complete aortic plan in minutes.
2025-11
Financial Post
ViTAA Medical Secures FDA 510(k) Clearance for AiORTAu2122 Plan -- Marking the First Step in Its Hyper-Precise Aortic Care Platform
ViTAA Medical Solutions Inc. announced FDA 510(k) clearance for AiORTAu2122 Plan, an automated aortic surgery planning solution, which is a significant step for their broader AiORTAu2122 platform. The platform aims to support physicians across the full continuum of aortic care.
2025-11
Medical Device Network
FDA clears ViTAA Medical's AI aortic surgery planning tool
ViTAA Medical's AiORTA Plan, an AI-based tool for aortic surgery planning, has received FDA clearance, marking the first milestone in the company's goal to bring a full spectrum aortic care platform to market. The tool assists physicians in preparing for complex aortic procedures.
2025-11
INOVAIT
From Risk to Hyper-Precision: How ViTAA Medical is leveraging imaging and AI to redefine Aortic Aneurysm Care
ViTAA Medical is utilizing AI-assisted 3D modeling to revolutionize aortic aneurysm management, moving beyond outdated size-based guidelines to incorporate multiple markers of vascular tissue strength and AI prediction. Their technology aims to improve the identification of patients who need surgery and those who do not.
2025-12
IGMPI
ViTAA's AiORTA Plan Receives FDA Clearance
ViTAA Medical has obtained FDA clearance for AiORTA Plan, an AI-powered tool that automates key preoperative tasks for complex aortic surgeries, including aneurysm segmentation and volumetric analysis. This is the initial component of their comprehensive aortic care platform, which will also include AiORTA Maps and AiORTA Watch.
2025-11
FDA
510(k) Premarket Notification - K250337 - AiORTA - Plan
The FDA granted 510(k) clearance for ViTAA Medical Solutions, Inc.'s AiORTA - Plan (K250337) on October 30, 2025. This device is an automated radiological image processing software intended for volumetric assessment and measurements based on 3D reconstruction from cardiovascular CTA scans.
2025-10
Journal of Vascular Surgery-Cases, Innovations and Techniques
AI-powered assessment of biomarkers for growth prediction of abdominal aortic aneurysms
This peer-reviewed article, published in July 2023, details an AI model developed by ViTAA Medical Solutions and academic partners to predict accelerated growth of abdominal aortic aneurysms using biomechanics-based biomarkers. The study showed very good performance in predicting faster than average growth.
2023-07
UCeed - University of Calgary
ViTAA Medical Solutions | UCeed - University of Calgary
ViTAA Medical Solutions, formed in 2019, received investment from UCeed, a venture philanthropy fund, to focus on obtaining regulatory approvals in the US and Canada for its AI and diagnostic imaging technology. This technology aims to more accurately assess aortic aneurysms.
unknown

Frequently Asked Questions

ViTAA offers the AiORTAu2122 platform, which includes AiORTAu2122 Plan for automated preoperative aortic surgery planning, AiORTAu2122 Maps for patient-specific vessel strength analysis, and AiORTAu2122 Watch for longitudinal monitoring and early complication detection. AiORTAu2122 Plan has received FDA 510(k) clearance, while Maps and Watch are currently in multicenter clinical studies.
ViTAA's technology moves beyond outdated size guidelines by using AI and diagnostic imaging to assess aneurysms more accurately, providing insights into vessel behavior and identifying vulnerable areas of the aorta with greater precision. Their AiORTAu2122 Maps tool generates a Regional Aortic Weakness (RAW) Score by analyzing CT scans for vessel-integrity insights like thrombus burden. This allows for more informed decision-making throughout the patient journey, potentially enabling earlier intervention for high-risk patients and avoiding unnecessary surgeries for lower-risk ones.
ViTAA's solutions leverage AI and computer vision to automatically generate key preoperative measurements from CT scans, such as aneurysm segmentation, centerline generation, and volumetric analysis. This cloud-based approach improves precision and reproducibility in aortic surgical interventions, reduces manual planning work, and provides a 'glassbox' AI model where every step is auditable and understandable by physicians.
ViTAA Medical Solutions has received FDA 510(k) clearance for its AiORTAu2122 Plan, which is a significant milestone for the company. This clearance validates their approach of combining automation with precision medicine, and the company is also focused on obtaining regulatory approvals in Canada.
ViTAA's AiORTAu2122 platform is a zero-footprint, web-based system that provides automated pre-operative case planning, integrating seamlessly into existing clinical workflows and reducing manual work. The AiORTAu2122 Watch component, currently in clinical studies, is being developed for real-time monitoring of aortic health and long-term post-operative endoleak surveillance and risk stratification, enabling early complication detection and continuous patient-specific vascular care.
ViTAA Medical Solutions partners with academic institutions like the University of Calgary, where its foundational technology was developed, and has received investment from funds like UCeed. While specific details on customer support were not explicitly found, their focus on integrating into clinical workflows and providing a comprehensive platform suggests a commitment to supporting healthcare providers in adopting their technology. They also exhibit at medical symposiums like VEITHsymposium.
ViTAA Medical Solutions was founded in 2019 and has secured funding, including a Series A round in January 2025, raising a total of $4.87M. Their FDA 510(k) clearance for AiORTAu2122 Plan in late 2025/early 2026 further indicates significant progress and market entry, suggesting a stable and growing company.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.